Hacker News new | ask | show | jobs
by aquadrop 2028 days ago
Shouldn't it warrant a research if even smaller dose has even higher efficiency?
1 comments

Yes. But clinical trials are expensive ($100m plus) and time consuming.
If both regimens underwent Phase 2 testing, there should be data on comparative immunogenicity.